Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. [electronic resource]
- Clinical cardiology Oct 2018
- 1281-1288 p. digital
Publication Type: Journal Article; Review
1932-8737
10.1002/clc.23055 doi
Carboxylic Acids--therapeutic use Cardiovascular Diseases--epidemiology Cholesterol, HDL--blood Fatty Acids, Omega-3--therapeutic use Global Health Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Hypertriglyceridemia--complications Incidence Randomized Controlled Trials as Topic--methods Risk Factors Triglycerides--blood